CD19+ Lymphoma, B-Cell
1 clinical trials · Condition
◉ Watch CD19+ Lymphoma, B-Cell
| Record | Firm | Date |
|---|---|---|
| ET190L1-ARTEMIS™ T Cells in Relapsed, Refractory B Cell Leukemia and Lymphoma (NCT03895944) | First Affiliated Hospital Xi'an Jiaotong University | 2017-12-06 |
Track CD19+ Lymphoma, B-Cell automatically
Every clearance here is in the API, with alerts when new ones post.